SCHEMBL10107030

SCHEMBL10107030

CC(C)CN(Cc1ccc2c(c1)OCCCO2)C(=O)C1CN(Cc2ccccc2)CCS1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 4/20 0.47
CYP2D6 P10635 1/20 0.44
ACHE P22303 3/20 0.43
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 2/20 0.40
PKM P14618 1/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
BCHE P06276 2/20 0.40
CHRM5 P08912 1/20 0.40
FAAH O00519 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
OPRD1 P41143 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564978 0.90 PROKR2 (0.58) PROKR2CYP2D6ACHEALDH1A1GAA
SCHEMBL564924 0.85 PROKR2 (0.58) PROKR2CYP2D6ACHEGAAKDM4E
SCHEMBL565459 0.85 PROKR2 (0.58) PROKR2CYP2D6ACHEGAAKDM4E
SCHEMBL10106578 0.85 PROKR2 (0.58) PROKR2CYP2D6ACHEGAAKDM4E
SCHEMBL565808 0.85 PROKR2 (0.58) PROKR2CYP2D6ACHEGAAKDM4E
SCHEMBL565601 0.85 KDM4E (0.59) PROKR2CYP2D6ACHEALDH1A1KDM4E
SCHEMBL387975 0.85 PROKR2 (0.63) PROKR2CYP2D6ACHEALDH1A1GAA
SCHEMBL3517508 0.85 PROKR2 (0.63) PROKR2CYP2D6ACHEALDH1A1GAA
SCHEMBL3516623 0.85 PROKR2 (0.63) PROKR2CYP2D6ACHEALDH1A1GAA
SCHEMBL564951 0.85 KDM4E (0.59) PROKR2CYP2D6ACHEALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885CYP2D6 3384/4885ACHE 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.